Τρίτη 29 Ιανουαρίου 2019
Is an elevated burden of antiarrhythmic drug (AAD) side-effects the unavoidable price to be traded for a durable suppression of AF relapses in ablated patients? The weaknesses and risks of the AAD suppression algorithm used by current models of AF secondary prevention after catheter ablation
http://bit.ly/2CQEwPB
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Visual impairment in kurdistan and trend of epidemiologic eye studies in Iran Per Kallestrup Journal of Ophthalmic and Vision Research 2019 ...
-
Abstract This Strategic Research Agenda identifies current challenges and needs in healthcare, illustrates how biomedical imaging and deri...
-
Google "metronome" from any internet connected device to use an adjustable, audible beat during chest compressions from EMS via ...
-
Lymphangitic carcinomatosis Publication date: Available online 21 May 2019 Source: Current Medicine Research and Practice Author(s): Dr She...
-
No abstract available from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2MTPKKX
-
https://ift.tt/2SSLiPA
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου